Rocket Lab USA Fell About 3% To Roughly $ 43 in Monday Trading Even As Recent Catalysts Remain Constructive, Infectuding Solid Q2 Results, In-Line Guidance, and Fresh Price-Target Hikes into the Mid- $ 50s.
- Q2 Snapshot: REVENUE ROSE 36% YEAR OVER YEAR TO $ 144.5 MILLION, ABOVE EXPECTATIONS NEAR $ 135 MILLION, WHILE EPS OF -$ 0.13 MISSED CONCENSUS BY $ 0.03; OPERATING LOSS NARROWED TO $ 33.6 MILLION VERSUS LARGER LOSS EXPECTED BY WALL STREET.
- Outlook: Management Guided Q3 Revenue to $ 145– $ 155 Million and Non -Gross Margin of 39%–41%, Essentially in Line at The Midpoint, with adjusted Ebitda LOSS OF $ 21– $ 23 MILLION.
- Backlog and Mix: The Total Backlog Stands AT Nearly $ 1 billion, with Space Systems Accounting for 59% and Launch Services for 41%, Indicating A Balanced Demand Across Segments.
- Neutron Progress: The Company Reiterated First Neutron Launch in 2H25; Stage 2 Has Been Cryo -Proofed and Is Heading to Launch Complex 3 in Virginia, With The Site’s Official Opening Slated for August 28, 2025, as Rocket Lab Lab Pushes to Reach The Pad This Year.
- Street Reaction: Stifel and Needham Raised Targets to $ 55 and Reiterated Buy, Citing Execution, Five Q2 Electron Launches, and Confidence in Neutron’s Late -Q inaugural Timeline; Consensus Remains Moderate Buy with Average Targets in the Low -To -Mid $ 40s Ahead of Post -Print Updates.
- Trading context: RKLB HAS CLIMBED SHARPL OVER THE PAST YEAR AND NOTILED AN ALL -TIME HIGH IN JULY; Recent Sessions Show Routine Volatility Around Earnings and Neutron Milestones As Investors Balance Valuation with Medium -Lift Optionality.
